High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
AIMS: Macrophages in atherosclerotic plaques secrete YKL-40. We tested the hypothesis if high serum YKL-40 concentration predicts coronary events and death of patients with stable coronary artery disease (CAD). METHODS AND RESULTS: During the 2.6 years follow-up period (median 2.77 year, interquartile range 0.23 year), 270 patients among the 4298 patients with stable CAD in the CLARICOR trial suffered myocardial infarction (MI) and 377 died (187 classified as cardiovascular death). Serum YKL-40 transformed as Y=log[max(82, serum YKL-40/microg/L)] was significantly associated with cardiovascular death [hazard ratio (HR) = 1.88, 95% confidence interval (CI) = 1.54-2.31, P < 0.001], all-cause mortality (HR = 2.01, 95% CI = 1.75-2.31, P < 0.001), and MI (HR = 1.38, 95% CI = 1.13-1.68, P = 0.002). Following multivariable adjustment for cardiovascular risk factors (age, sex, previous MI, smoking status, hypertension, diabetes mellitus) and selected medical treatments Y contributed significantly to prediction of all-cause mortality (P < 0.001) and cardiovascular mortality (P = 0.001), but not MI (P = 0.25). CONCLUSION: High serum YKL-40 is associated with MI, cardiovascular and all-cause mortality in patients with stable CAD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493 · cited 2×
“In the analysis of myocardial infarction only that of ACE-inhibitor treatment was included. ow nloaded from https://academ ic.oup.com /eurheartj/article-abstract/30/9/1066/478867 by guest on 16 M arch 2020 Since risk factors such as BMI, renal status, as well as other potential biomarkers were not measured in the pres…”
BackgroundInflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304
Sabatine, M. S., Morrow, D. A., Jablonski, K. A., Rice, M. M., Warnica, J. W., Domanski, M. J., Hsia, J., Gersh, B. J., Rifai, N., Ridker, P. M., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.649939 · Cited by 385
Diurnal, weekly, and long-time variation in serum concentrations of YKL-40 in healthy subjects
Johansen, J. S., Lottenburger, T., Nielsen, H. J., Jensen, J. E. B., Svendsen, M. N., Kollerup, G., & Christensen, I. J. (2008) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2766 · Cited by 72 · cited 1×
“This method takes less than 4 h, has low intra- and inter-assay coefficients of variation, and the intraclass correlation coefficient indicated reasonable reliability of serum YKL-40 measurements and relatively small variation in healthy subjects.(34)”
MethodSelf-citation
Cited by
Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques
Langley, S. R., Willeit, K., Didangelos, A., Matic, L. P., Skroblin, P., Barallobre-Barreiro, J., Lengquist, M., Rungger, G., Kapustin, A., Kedenko, L., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci86924 · Cited by 174
Chitinases: in agriculture and human healthcare
Nagpure, A., Choudhary, B., & Gupta, R. K. (2014) · Critical Reviews in Biotechnology · doi:10.3109/07388551.2013.790874 · Cited by 145
“A large study of 4298 patients with IHD showed that plasma YKL-40 was a strong biomarker for cardiovascular death and all-cause mortality during 2.6 years follow-up period (Kastrup et al., 2009).”
BackgroundInfluentialYKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis
Arain, F., Abraityte, A., Bogdanova, M., Solberg, O. G., Michelsen, A. E., Lekva, T., Aakhus, S., Holm, S., Halvorsen, B., Finsen, A. V., et al. (2020) · Circulation: Heart Failure · doi:10.1161/circheartfailure.119.006643 · Cited by 13
Metadata
- Authors
- Kastrup, J., Johansen, J. S., Winkel, P., Hansen, J. F., Hildebrandt, P., Jensen, G. B., Jespersen, C. M., Kjoller, E., Kolmos, H. J., Lind, I., Nielsen, H., Gluud, C., & the CLARICOR Trial Group
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-03-06
- Volume
- 30
- Issue
- 9
- Pages
- 1066-1072
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2039297524
- Cited by
- 158
- References
- 4
- FWCI
- 14.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. https://app.cochat.ai/papers/10.1093/eurheartj/ehp049
- The paper
- Kastrup, J., Johansen, J. S., Winkel, P., Hansen, J. F., Hildebrandt, P., Jensen, G. B., Jespersen, C. M., Kjoller, E., Kolmos, H. J., Lind, I., Nielsen, H., Gluud, C., & the CLARICOR Trial Group. (2009). High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease. European Heart Journal. https://doi.org/10.1093/eurheartj/ehp049
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.